Oral administration of a liquid containing nitrous oxide abolishes vaso-occlusive pain in mice with sickle cell disease
Open Access
- 5 June 2025
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 110 (12) , 3114-3118
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell diseaseBlood, 2020
- The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioidsPain, 2020
- Nitrous oxide and vitamin B12 in sickle cell disease: Not a laughing situationMolecular Genetics and Metabolism Reports, 2020
- Nitrous Oxide, From the Operating Room to the Emergency DepartmentCurrent Emergency and Hospital Medicine Reports, 2016
- Quantification of pain in sickle mice using facial expressions and body measurementsBlood Cells, Molecules, and Diseases, 2016
- Nitrous Oxide for the Treatment of Chronic Low Back PainAnesthesia & Analgesia, 2015
- Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by ChemotherapyThe Journal of Neuroscience, 2012
- Biologic Effects of Nitrous OxideAnesthesiology, 2008
- Advances in Understanding the Actions of Nitrous OxideAnesthesia Progress, 2007
- Cold water exposure and vaso-occlusive crises in sickle cell anemiaThe Journal of Pediatrics, 1991